loading
Precedente Chiudi:
$1.40
Aprire:
$1.41
Volume 24 ore:
329.47K
Relative Volume:
2.14
Capitalizzazione di mercato:
$24.59M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-2.00
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
+0.00%
1M Prestazione:
-7.89%
6M Prestazione:
-2.10%
1 anno Prestazione:
-24.32%
Intervallo 1D:
Value
$1.3804
$1.44
Intervallo di 1 settimana:
Value
$1.15
$1.46
Portata 52W:
Value
$0.94
$2.55

NanoViricides Inc Stock (NNVC) Company Profile

Name
Nome
NanoViricides Inc
Name
Telefono
203-937-6137
Name
Indirizzo
1 Controls Drive, Shelton, CT
Name
Dipendente
7
Name
Cinguettio
@nnvcnyse
Name
Prossima data di guadagno
2025-05-20
Name
Ultimi documenti SEC
Name
NNVC's Discussions on Twitter

Confronta NNVC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NNVC
NanoViricides Inc
1.40 24.59M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-02-11 Iniziato Midtown Partners Strong Buy

NanoViricides Inc Borsa (NNVC) Ultime notizie

pulisher
Jun 18, 2025

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu - citybuzz -

Jun 18, 2025
pulisher
Jun 18, 2025

Small cap wrap: Fineqia, NanoViricides, Standard Uranium... - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides touts antiviral NV-387 as tool against new COVID variant - Proactive financial news

Jun 18, 2025
pulisher
Jun 10, 2025

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in AfricaPhase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu - The Columbus Dispatch

Jun 10, 2025
pulisher
Jun 05, 2025

NanoViricides Advances Measles Drug Program as Global Outbreaks Rise - citybuzz -

Jun 05, 2025
pulisher
Jun 04, 2025

NanoViricides Measles Drug Development Animal Study is Imminent - Akron Beacon Journal

Jun 04, 2025
pulisher
Jun 04, 2025

Small cap wrap: NanoViricides, New Era Helium, Charbone Hydrogen, Voyageur Pharmaceuticals... - Proactive Investors

Jun 04, 2025
pulisher
Jun 04, 2025

NanoViricides commissions animal study of broad-spectrum antiviral for measles - Proactive Investors

Jun 04, 2025
pulisher
Jun 04, 2025

NanoViricides (NNVC) Advances Measles Drug Development | NNVC St - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Breakthrough Measles Drug Enters Critical Testing Phase as Global Cases Surge 10X - Stock Titan

Jun 04, 2025
pulisher
Jun 02, 2025

Nanoviricides (NNVC) To Unveil 'Escape-Proof' Antiviral Platform At Major Biotech Convention - MENAFN.com

Jun 02, 2025
pulisher
Jun 02, 2025

NanoViricides (NNVC) to Unveil 'Escape-Proof' Antiviral Platform at Major Biotech Convention - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Gold Is Bullish, But Be Aware Of Deeper Intraday Pullback; Elliott Wave Intraday Analysis - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

NanoViricides (NNVC) to Unveil ‘Escape-Proof’ Antiviral Platform at Major Biotech Convention - The Globe and Mail

Jun 02, 2025
pulisher
May 28, 2025

NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025 - Lohud

May 28, 2025
pulisher
May 28, 2025

NanoViricides to Showcase Breakthrough Antiviral Platform at BIO International Convention - citybuzz -

May 28, 2025
pulisher
May 28, 2025

Hudbay Receives TSX Approval for Normal Course Issuer Bid - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

NanoViricides to present at BIO International Convention 2025 in Boston - Proactive financial news

May 28, 2025
pulisher
May 22, 2025

NanoViricides president backs FDA's targeted COVID booster policy shift - Proactive financial news

May 22, 2025
pulisher
May 22, 2025

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan - ACCESS Newswire

May 22, 2025
pulisher
May 17, 2025

Small cap wrap: NanoViricides, Trust Stamp, NextSource, StickIt... - Proactive financial news

May 17, 2025
pulisher
May 16, 2025

NanoViricides advances NV-387 antiviral program, eyes Phase II trials for Mpox - Proactive Investors

May 16, 2025
pulisher
May 16, 2025

NanoViricides: MPox ethics approval enables Phase 2 application - Proactive Investors

May 16, 2025
pulisher
May 16, 2025

NanoViricides: Fiscal Q3 Earnings Snapshot - Huron Daily Tribune

May 16, 2025
pulisher
May 15, 2025

Small cap wrap: atai, Black Swan Graphene, TNR Gold, NanoViricides... - Proactive financial news

May 15, 2025
pulisher
May 14, 2025

NanoViricides progresses antiviral portfolio as measles and MPox threats rise - Proactive financial news

May 14, 2025
pulisher
May 14, 2025

Measles Cases Are Increasing Globally; MPox Continues to Be a ThreatBroad-Spectrum Antiviral Drug Could Be the Solution - The Derrick

May 14, 2025
pulisher
May 13, 2025

AMAT Likely to Beat Q2 Earnings Estimates: How to Play the Stock - The Globe and Mail

May 13, 2025
pulisher
May 08, 2025

Small cap wrap: NanoViricides, Alvopetro, Polarean... - Proactive financial news

May 08, 2025
pulisher
May 08, 2025

NanoViricides wins ethics approval for Phase II Mpox drug trial in DRC - Proactive financial news

May 08, 2025
pulisher
May 08, 2025

Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo - The Derrick

May 08, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Buys 30,800 Shares of NanoViricides, Inc. (NYSE:NNVC) - Defense World

May 07, 2025

NanoViricides Inc Azioni (NNVC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):